Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
iomeron 200 mg i/ml injektionsvätska, lösning
bracco imaging spa - jomeprol - injektionsvätska, lösning - 200 mg i/ml - jomeprol 408 mg aktiv substans - jomeprol
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
iomeron 250 mg i/ml injektionsvätska, lösning
bracco imaging spa - jomeprol - injektionsvätska, lösning - 250 mg i/ml - jomeprol 510 mg aktiv substans - jomeprol
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
iomeron 300 mg i/ml injektionsvätska, lösning
bracco imaging spa - jomeprol - injektionsvätska, lösning - 300 mg i/ml - jomeprol 612 mg aktiv substans - jomeprol
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
iomeron 350 mg i/ml injektionsvätska, lösning
bracco imaging spa - jomeprol - injektionsvätska, lösning - 350 mg i/ml - jomeprol 714 mg aktiv substans - jomeprol
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
iomeron 400 mg i/ml injektionsvätska, lösning
bracco imaging spa - jomeprol - injektionsvätska, lösning - 400 mg i/ml - jomeprol 816 mg aktiv substans - jomeprol
Европейски съюз -
шведски -
EMA (European Medicines Agency)
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium bromid - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
kappadi 25 mg filmdragerad tablett
alfa wasserman spa - diklofenakkalium - filmdragerad tablett - 25 mg - diklofenakkalium 25 mg aktiv substans; natriumlaurilsulfat hjälpämne; mannitol hjälpämne - diklofenak
Швеция -
шведски -
Läkemedelsverket (Medical Products Agency)
kappadi 50 mg filmdragerad tablett
alfa wasserman spa - diklofenakkalium - filmdragerad tablett - 50 mg - natriumlaurilsulfat hjälpämne; mannitol hjälpämne; diklofenakkalium 50 mg aktiv substans - diklofenak
